Form 8-K - Current report:
SEC Accession No. 0001683168-17-000150
Filing Date
2017-01-23
Accepted
2017-01-23 16:09:22
Documents
3
Period of Report
2017-01-17
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K sonoma_8k.htm 8-K 13243
2 CODE OF BUSINESS CONDUCT sonoma_8k-ex1401.htm EX-14.1 61750
3 GRAPHIC sonoma_logo.jpg GRAPHIC 5341
  Complete submission text file 0001683168-17-000150.txt   83746
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 17541144
SIC: 2834 Pharmaceutical Preparations